Early clinical experience with cimetidine in duodenal ulcer patients.
J. Groarke, Oliver FitzGerald
Abstract
J. Groarke, Oliver FitzGerald
Abstract
Nineteen patients with duodenal ulcer have been treated with cimetidine 1.2 G daily for six weeks. All experienced striking symptomatic improvement. Measurement of gastric secretion showed that tolerance to cimetidine had not developed after six weeks treatment. No significant side effects were noted. Cimetidine appears to be a safe and effective means of controlling duodenal ulcer symptoms. Controlled trials are indicated.
OpenAlex reports 8 citations for this work. Citation counts describe recorded attention and do not establish research quality.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Nineteen patients with duodenal ulcer have been treated with cimetidine 1.2 G daily for six weeks. All experienced striking symptomatic improvement. Measurement of gastric secretion showed that tolerance to cimetidine had not developed after six weeks treatment. No significant side effects were noted. Cimetidine appears to be a safe and effective means of controlling duodenal ulcer symptoms. Controlled trials are indicated.
Key concepts: Cimetidine, Duodenal ulcer, Medicine, Gastroenterology, Internal medicine, Gastric secretion, Clinical trial, Stomach